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1. Introduction   
Worldwide, traumatic brain injury is one of the leading cause of permanent disability and 
death. Contextually, close monitoring and immediate therapy for any accompanying 
abnormalities are crucial in order to reduce the rate of mortality or morbidity associated 
with this acquired brain injury. For this purpose, an isolated neurointensive care (NIC) 
specialised for brain injury is highly warranted, manned by appropriately trained staff who 
understand the current pathophysiology of brain injury and equipped with various modes 
of therapy to tackle any diagnosed abnormalities. To date, we are witnessing progress in 
managing severely injured brain from no specific monitoring to specific ones, and from a 
single intracranial pressure monitoring to future trend of multiple cranial monitoring 
alongside availability of various mode of therapies. The multimodal brain monitoring as it is 
commonly known is a concept whereby, intracranial pressure as well as various other 
important cerebral parameters can readily be monitored.  
Monitoring alone will not alter the outcomes of severely injured brain patients. Prompt 
recognition of any abnormality from the monitoring and availability of therapy to correct 
the diagnosed abnormality are some of the factors that are recognised to influence better 
outcome score. However, at present, two obvious limitations in the multimodality brain 
monitoring are our incomplete understanding of the underlying pathophysiology of the 
severely injured brain and the limited availability of mode of therapy to the neurosurgeon 
or neurointensivist to treat abnormalities detected from the state-of-the-art monitoring. 
Research are ongoing in these areas and in this chapter, we discuss in details the current 
pathophysiology of traumatic brain injury, roles of multimodality brain monitoring in NIC 
and the prospects of brain hypothermia to correct commonly associated abnormal 
monitored-parameters. 
2. Pathophysiology underlying severely injured brain   
Closed brain injury processes can be divided into two phases, primary and secondary brain 
injury. The primary brain injury occurs during the initial insult. The severity and type of 
impact incurred during the initial insult will substantially influence the structural lesions 
that ensue. This severely injured brain is vulnerable to further insult which is known as the 
secondary brain injury (figure 1). In this phase, the commonly associated forms of insult can 
be broadly categorised into three: 1) intracranial hypertension; 2) cerebral hypoxia and 
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hypoperfusion which can lead to hypoxic-ischaemic damage and 3) electrographic seizures. 
These secondary insults can progress to three major forms of end-stage events: 1) cerebral 
infarct; 2) cerebral or brain swelling and 3) herniation syndromes, all of which impose a 
negative impact on outcome. Alternatively, pathophysiology of brain injury can be viewed 
consisting of three components: 1) macroscopic pathophysiological events or primary brain 
injury; 2) microscopic pathophysiological events which are part of secondary brain injury 
consisting of intracranial hypertension, cerebral ischaemia and hypoxia, and electrographic 
seizures and finally 3) ultramicroscopic events which are also part of secondary brain injury 
processes including cascades of glial cells and molecular events, microvascular dysfunction, 
blood brain barrier (BBB) disruption, inflammatory cells recruitment and reactivation, and 
immunological response. All of these, macroscopic, microscopic and ultramicroscopic 
processes or events are related to patient‘s outcome. The ‘micro‘ and ‘ultramicro’ 
pathophysiological events are potentially avoidable and amenable to treatment. Currently, 
the primary focus in the acute management of traumatic brain injury is to prevent and 
ameliorate these micro and ultramicroscopic events that accentuate secondary brain injury. 
In practice, the multimodality brain monitoring to certain extent, bears much reflection of 
these complex inter-related events, and hence explains the rationale of such monitoring 
approach in severely injured brain as we attempt to expand our scientific understanding on 
this complex issue.   
 
 
Fig. 1. Schematic flow of events in the pathophysiology of traumatic non penetrating 
(closed) brain injury 
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2.1 Primary and secondary brain injury 
Primary brain injury occurs at the time of impact with an instantaneous clinical effect. 
Pathological classification for this form of injury is largely evident either clinically or by 
imaging (macroscopic events) which include focal-epidural, subdural, intracerebral 
haematomas, focal contusion and laceration, focal or diffused subarachnoid haemorrhage 
and focal or diffused axonal and vascular injuries. Surgery plays a major role to treat some 
of these pathologies. On the other hand, secondary brain injury or damage occurs at some 
stage after the initial impact and therefore can aggravate the primary brain injury. From 
figure 1, it is apparent that the microscopic and ultramicroscopic events contribute to the 
secondary brain injury pathogenesis. However, currently there are limited treatment options 
available in treating the secondary brain injury processes or damages. In 2002, Narayan 
reviewed clinical trials in head injury and concluded that most trials assessing 
pharmacological neuroprotective agents failed to show clinically robust efficacy (Narayan et 
al., 2002). Surgically, the typical available options are burr hole and cerebrospinal fluid 
(CSF) drainage and a wide decompressive craniectomy. The latter has regained therapeutic 
interest in the past years with beneficial effects shown for massive brain infarcts, brain 
swelling and brain herniation that constitute the end results of secondary brain injury 
processes as discussed above (Carandang & Krieger, 2008; Cooper et al., 2008; Eberle et al., 
2010; Figaji et al., 2007). Other possible alternatives to treat secondary brain damage include 
therapeutic cerebral hypothermia (Dietrich & Bramlett, 2010; Gluckman et al., 2005), 
barbiturates therapy (Marshall et al., 2010), raising cerebral blood flow and perfusion by 
using pressors (Lewis et al., 1998) and rheological agents such as mannitol and hypertonic 
saline therapy (Berger et al., 1995; Oddo et al., 2009). 
2.1.1 Ultramicroscopic events 
Trauma will induce a significant and protracted inflammatory, molecular, microvascular 
and immunological responses. These response cascades following direct damage to the 
neurovascular unit which incite ischaemic-hypoxic events. Systematically, four major 
mechanisms may contribute to cerebral ischaemia or hypoxia: a) direct or indirect structural 
damage to intracerebral arteries, neurons and glial cells (neurovascular unit); b) 
cerebrovascular-metabolic uncoupling; c) intracranial hypertension and, d) vasospasms of 
cerebral artery. These mechanisms are the interrelated cascades which underlie the 
pathophysiological processes that propagate the brain injury (figure 2). Damage to the 
neurovascular unit which comprises cerebral endothelial cells, astrocytes and neurons as 
well as extracellular matrix plays significant role in these cascades (Dirnagl et al., 1999). The 
cascades involved opening of voltage dependent and agonist-gated ion and calcium 
channels causing intracellular calcium and sodium overload and efflux of potassium. 
Intracellular sodium overload causes cytotoxic oedema while efflux of potassium leads to 
peri-infarcted brain tissue depolarisation and seizures. Influx of calcium is further promoted 
by the release of large amount of excitatory amino acids particularly glutamate. Intracellular 
calcium and glutamate act in a vicious circle which augments the amount of intracellular 
calcium. Excess intracellular calcium can induce damage to the organelles such as 
mitochondria, intracellular second messengers, cellular membrane and activation of 
numerous intracellular enzymes system which finally lead to apoptosis. Apoptosis is a form 
of cell death in which a programmed sequence of events leads to the elimination of cells 
without releasing much harmful substances. When brain cells experienced an injury or 
episode of ischaemia, they either become dead and the area involved is better known as 
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infarcted area, or the cells may survive the injuries and in time recover completely or 
partially, or alternatively the cells enter the apoptotic pathway. Interestingly, during the 
early stages of injury, the process of apoptosis can still be reversed. This reversal is made 
possible by correcting the cellular energy metabolism or cerebrovascular metabolic coupling 
or by lowering the brain temperatures (Liou et al., 2003). In addition to the events described 
above, damage to the neurovascular unit can also cause production of free radicals. Free 
radicals are atomic or molecular species with unpaired electrons. They are highly reactive 
and unstable, therefore capable of oxidizing and damaging all cellular components when 
their amounts exceed the anti-oxidant defence mechanisms as seen in episode of 
ischaemia/reperfusion brain injury (Lewen et al., 2000). Other harmful events that occur at 
ultramicroscopic levels when the brain is injured are inflammatory and immunological 
responses. Increased levels of pro-inflammatory cytokines such as interleukin-6 (IL-6), 
interleukin-8 (IL-8), interleukin-10 (IL-10) and tumour necrosis factor alpha (TNF-α) have 
been demonstrated in cerebrospinal fluid, serum and brain tissue following head injury 
(Csuka et al., 1999; Is et al., 2007; Kossmann et al., 1997). The underlying dynamics of 
inflammation in traumatic brain injury are complex, encompassing cytokines, chemokines, 
adhesion molecules, complement factors and even the free radicals. The lead triggers for 
inflammatory activation are multi-factorial and thought to involve factors such as 
extravasated blood products, intracellular components, reactive free oxygen and nitrogen 
radicals by brain resident microglia and astrocytes sensing perturbation of tissue 
homeostasis (Juliet et al., 2008; Mathew et al., 1994). These initial events fuel further release 
of inflammatory mediators which facilitate influx of extracerebral inflammatory cells by 
vascular endothelial changes and chemotaxis. Studies have also shown the role of adhesion 
molecules such as vascular cell adhesion molecule, P-selectin, intracellular adhesion 
molecule-1 and gradient of chemotactic chemokines in upregulating these events 
(Hausmann et al., 1998). The ensuing extracellular oedema is triggered by vascular 
dilatation and leakage as a result of vasoactive inflammatory molecules such as nitric oxide 
(NO) and vascular endothelial growth factor, as well as activations of complement system 
by dying cells to aggravate the initial inflammation and secondary tissue damage (Grzybicki 
et al., 1998; Stahel et al., 1998). Currently, monitoring of neuroinflammation is only made 
possible with techniques such as brain microdialysis, whilst others such as free radical 
imaging and monitoring remains under intensive research (Vergely et al., 2003).  
2.1.2 Microscopic events 
Typically in normal subjects, the cerebral blood flow (CBF) and metabolism are a coupled 
phenomenon. Cerebrovascular metabolic uncoupling is reported to occur in over half of 
brain injured patients (Obrist et al., 1984). Uncoupling, which impairs the CBF and 
metabolism following traumatic severe brain injury is related to unfavourable functional 
outcome because of the correlation with ischaemic-hypoxic events. Reduction in CBF is 
obviously affecting the status of cellular metabolism and hence promoting cellular death. 
Interestingly, uncoupling is also expected with an excessive increased in CBF (luxury 
perfusion or hyperaemia) which is harmful to the injured brain by causing brain swelling 
(congested brain) or oedema. In 2007, Menashe Zaaroor noted significant reduction in CBF 
within 24 hours of brain injury and then increased at the second day after the injury. Further 
analysis revealed patients with good outcome after head injury had stable and normal CBF 
after initial period of significant reduction, whereas in patients with poor outcome, the 
course of CBF is triphasic with a secondary decrease on the third day post trauma (Menashe 
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Zaaroor et al., 2007). They postulated the subsequent decrease in CBF may be due to brain 
swelling or persistent impairment in cerebral autoregulation with disruption in blood brain 
barrier (BBB). In addition, persistent ischaemic insults would subsequently progress 
towards destructive processes involving disintegration of cell membranes and intracellular 
organelles, failure of various ion pumps, development of mitochondrial dysfunction, 
inappropriate activation of numerous enzyme systems with cellular hyperactivity and 
increment in lactate levels. All these contribute to the development of intracellular acidosis 
and retention of carbon dioxide which can further aggravate the preceding insults which 
could finally lead to cerebral oedema, swelling and peri-infarct cerebral depolarisation. The 
ultramicroscopic and microscopic cascades as illustrated in figure 2, depict the 
pathophysiological mechanisms acting in vicious circle, with the consequential brain 
swelling and oedema that inflict intracranial hypertension and reduction in cerebral 
perfusion pressure (CPP). The reduction in CPP further aggravates the ischaemia and 
encourages local release of vasoactive mediators such as endothelin, thomboxane A2 and 
prostaglandin I2. Endothelin and thromboxane A2 are powerful vasoconstrictor, whereas 
prostaglandin I2 is a potent vasodilator. Thromboxane can also induce platelet aggregation. 
Thromboxane and prostaglandin I2 play an important role in regulating local cerebral blood 
flow. This local homeostasis may be disrupted following an ischaemic event or direct 
neurovascular injury, with a relative increase in the production of thromboxane (Chen et al., 
1986). The predominant increase in thromboxane can lead to vasoconstriction and hence 
further reduces cerebral perfusion and also promotes local thrombus formation. Aside from 
the mechanisms involved in cerebral hypoperfusion state in brain injury as highlighted 
above, cerebral vasospasm could also play a pivotal role. An obvious culprit to this is the 
presence of blood products such as haemoglobin that act through multiple mechanisms. 
Such mechanisms include decreased production of a vasodilator such as NO, increased 
vasoconstrictors, free radical production and lipid peroxidation of cell membranes, 
modification of potassium and calcium channels, direct oxidative stress on smooth muscle 
cells, differential up-regulation of genes and cortical spreading depolarisation. The state of 
cortical spreading depolarisation or depression inverses the coupling between spreading 
depolarisation of the cortex and CBF by increasing the extracellular potassium and endothelin 
concentration and decreasing NO concentration. This finally leads to microarterial spasm and 
spreading cerebral ischaemia which act in a vicious circle (Pluta et al., 2009). In addition, 
cortical spreading depolarisation arising from peri-infarcted brain tissues (peri-infarcted 
depolarisation) underlying an ischaemic brain can also induce subclinical or non-convulsive 
seizures which can worsen the brain ischaemia (Fabricius et al., 2008).   
3. Neurointensive care monitoring 
The neurointensive care (NIC) warded critical patients who are mostly intubated. To the 
clinician, the clinical status assessment or monitoring for intubated patients are difficult. 
Hence, various important patients’ parameters must be monitored. Monitoring should 
therefore be focused on two categories; a) standard monitoring and b) specific monitoring. 
The standard NIC monitoring covers multiple vitals including the brain and other organ 
systems. The specific monitoring is focused mainly on the brain. Monitoring the pressure 
inside the cranium is regarded by most as the gold standard for severely injured brain 
patients in NIC (Ross & Eynon, 2005). Our latest understanding of the macroscopic, 
microscopic and ultramicroscopic pathophysiological events that underlie brain injury has  
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Fig. 2. A hypothetical scheme to depict post-traumatic and post-ischaemic events. ** 
treatment available; *monitoring only; orange boxed - no treatment yet, but under intensive 
research (BBB – Blood brain barrier; NO – Nitric oxide) 
widened our scopes of monitoring. Although intracranial hypertension is one of the main 
pathophysiological processes involved in secondary brain injury, it is not the sole predictor 
of the patient’s outcome. Notably, the observed intracranial hypertension in severely injured 
brain is a common end-point of the various pathophysiological cascades involved. Hence, 
other cerebral-specific monitoring parameters are required to assist neurointensivists detect 
‘earlier’ secondary insults and prevent the harmful progression to three end-stage processes 
as mentioned earlier, i.e. a) cerebral infarct b) brain swelling and oedema and c) herniation 
syndromes. The ‘extra’ monitoring parameters include cerebral blood flow, oxygenation, 
metabolites, brain temperature and perfusion, or otherwise known as the multimodality 
monitoring.   
3.1 Standard monitoring 
The severely injured brain is vulnerable to further insults after sustaining the traumatic 
primary brain injury. The secondary insults are commonly identified as systemic hypoxia 
and hypotension, intracranial hypertension and cerebral hypoperfusion which can progress 
to cerebral ischaemia, brain swelling and herniation syndrome. These secondary insults are 
regarded as the survival determinants for patients receiving care in the NIC. Therefore the 
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aim of standard monitoring is to prevent or to recognize these potential threats which could 
originate from other body systems besides the brain. Head injured patients in NIC should be 
monitored for nine key body systems: a) central nervous system (discussed specifically 
under brain monitoring); b) cardiovascular system which includes parameters such as heart 
rate and rhythm, blood and venous pressure, stroke volume, cardiac output and total 
peripheral resistance; c) pulmonary system with regular monitoring of arterial blood gases, 
chest radiographs, and breathing and ventilator parameters; d) renal and metabolic system 
with regular blood, urine and metabolic profiles monitoring; e) gastrointestinal and 
nutritional status pertaining to body calories; f) hematological profiles; g) microbiologic and 
sepsis profiles; h) peripheries and skin condition and lastly i) endocrine and hormonal 
profiles which are frequently overlooked, except for features of diabetes insipidus or 
syndrome of inappropriate antidiuretic hormone hypersecretion. Recent studies have 
demonstrated 75% incidence of endocrine dysfunction at 6 months post trauma in children 
and 21% incidence of hypothalamic-pituitary dysfunction in adults (Kaulfers et al., 2010; 
Krahulik et al., 2010). These findings prompted debates as to whether hormonal profile 
evaluation should be routinely checked in all head injured patients and treated accordingly. 
3.2 Specific monitoring 
Since limitations exist in bedside neurological findings as a monitoring tool for various 
pathophysiological processes described in previous sections, specific central nervous system 
monitoring is needed for severe brain injured patients in the NIC. The use of serial 
computed tomography (CT) brain scanning protocol to predict the presence or absence of 
abnormality or raised ICP has not been well received in practice, partly due to poor 
correlations between CT findings and raised ICP, and because of undesirable effects from 
repeated radiation exposure and frequent mobilization to the patients (Kouvarellis et al., 
2011; Miller et al., 2004). Therefore, specific brain monitoring seems necessary. Currently, 
the assessment of intracranial status for severely injured brain is commonly done with gold 
standard ICP monitoring alone. Lately, as our understanding on the complex 
pathophysiology underlying severely injured brain expands, new modalities of brain 
monitoring emerge, incorporating various brain parameters known as the multimodality 
monitoring (Idris et al., 2007; Isa et al., 2003; Stuart et al., 2010). 
4. Multimodality monitoring 
The development of new neuromonitoring techniques has been particularly important 
because typically standard cranial monitoring techniques such as ICP and CPP 
measurements seem insufficient in detecting subtle manifestations of brain injury or poor 
surrogates for physiologic parameters of interest. For these reasons, multimodality 
monitoring which monitors more brain parameters is required. Multimodality monitoring 
includes monitoring of the following parameters: 
i. Intracranial pressure (ICP)  
ii. Cerebral perfusion pressure (CPP) 
iii. Cerebral blood flow (CBF parameters) 
iv. Focal and global cerebral tissue oxygenation (PtiO2 and SjVO2) 
v. Cerebral tissue carbon dioxide tension (PtiCO2) 
vi. Cerebral pH  
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vii. Cerebral temperature 
viii. Cerebral metabolic parameters (brain microdialysis) 
ix. Cerebral EEG (EEG and BIS) 
x. Cerebral evoked potentials (somatosensory, brainstem and visual evoked potentials: 
SSEP/BAEP/VEP) 
Figure 3 shows the role of multimodality monitoring for the injured brain. Intracranial 
pressure is used to monitor the cranial pressure, Licox or Neurotrends system is used to 
monitor status of regional brain oxygenation, carbon dioxide tension, pH and brain 
temperature, while jugular bulb oximetry is used to monitor global brain oxygenation. Saber 
cerebral blood flow, transcranial doppler, cerebral EEG and evoked potentials can be used 
to monitor cerebral blood flow and therefore identifying ischaemic insults, and cerebral 
microdialysis can monitor the cellular events. Furthermore, continuous EEG monitoring in 
NIC can also diagnose the subclinical seizures which play significant role in secondary brain 
injury and one of the parameters that determine the prognosis (Kazibutowska et al., 1992). 
 
 
Fig. 3. Multimodality monitoring and secondary brain injury. 
5. Two major parameters to consider during multimodality monitoring: ICP 
and CBF 
Intracranial hypertension causes a reduction in cerebral perfusion pressure which can lead 
to ischaemia, brain swelling and ultimately infarction. In addition, persistent increased in 
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ICP could cause a shift in intracranial structures (midline shift or mass effect) and finally 
herniation syndromes. Therefore, monitoring ICP is considered a standard part of head 
injury management. Nonetheless, monitoring the ICP alone seems inadequate, because 
raised in ICP in head injured patients can be associated with both an increment and a 
reduction in CBF (Menashe Zaaroor, 2007). In 1992, Bouma noted about one-third of head 
injured patients had low CBF and therefore showed an early cerebral blood flow-
metabolism mismatch (Bouma et al., 1992). Figure 2 highlights the importance of CBF 
monitoring to prevent or reduce the degree of cerebral ischaemic-hypoxic insults. Whilst the 
optimal method for measuring CBF remains to be established, there are numerous 
alternatives when used together can estimate the CBF. Those alternatives include: a) CPP; b) 
blood flow velocity by transcranial doppler; c) focal and global cerebral oxygenation with 
Licox or Neurotrends systems or jugular bulb oximetry; d) regional CBF with Saber 2000; e) 
cerebral metabolic parameters with brain microdialysis; f) cerebral perfusion imaging 
techniques and g) cerebral evoked potentials and EEG. These are in fact features of 
multimodality neuromonitoring.  
The CBF and CPP are two variables that are inter-related. The CBF is proportional to CPP 
and inversely related to the cerebral vascular resistance (CVR). The CPP represents the 
pressure gradient driving CBF and hence oxygen and metabolite delivery, i.e. in other 
words, the CPP is the perfusion pressure gradient across cerebral vascular bed whereby the 
incoming systemic arterial pressure minus the opposing force from venous outflow 
pressure. In traumatic brain injury cases, the elevated ICP is the opposing force to the 
incoming mean systemic arterial pressure (MAP). Therefore, CPP in equation form can be 
stated as CPP = MAP – ICP. In theory, CPP is equivalent to the transmural pressure across 
the cerebral vessel walls. In other words, at the arteriolar level, CPP is the stimulus for 
autoregulatory response and at the capillary, it is the driving force for fluid exchange. The 
normal brain autoregulates its blood flow to provide a constant flow regardless of blood 
pressure by altering the CVR to obtain a maintained flow within an autoregulatory range of 
60 - 160 mmHg of MAP or CPP of 50 – 150 mmHg. These homeostatic mechanisms are often 
lost in severely injured brain due to impairment in cerebral autoregulation, implying that 
cerebral autoregulation is a homeostatic mechanism that minimizes deviations in CBF when 
CPP or MAP changes. It acts through vasomotor effectors that control CVR. Vasomotor 
effectors are controlled by a) CPP; b) metabolites; c) oxygen pressure; d) carbon dioxide 
pressure and e) temperature. In NIC setting, the level of changes in cerebral autoregulation 
among patients is individualised and therefore the optimum CPP may vary considerably. 
Clinically, continuous methods of autoregulation tests or monitoring rely on the observation 
of spontaneous responses of CBF to spontaneous fluctuations in MAP or CPP (Zweifel et al., 
2008), arterial partial pressure of CO2 (Puppo et al., 2008)  or metabolites (Lee et al., 2001). 
Study by Lee in 2001 showed that during the first 2 weeks after head injury, CO2 reactivity 
remains relatively intact, pressure autoregulation is variably impaired and metabolic 
suppression reactivity remains severely impaired and they further noted that unlike 
hypotension, hypoxia or haemorrhagic brain lesions, elevated ICP appears to affect  
all components of vasoreactivity that were tested (Lee et al., 2001). In similar year, Czosnyka 
also noted that autoregulation is not only impaired when associated with a high ICP or low 
arterial blood pressure, but it can also be disturbed by an excessive CPP (Czosnyka et  
al., 2001). Studies have shown that impairment or failure of autoregulation can contribute  
to unfavorable outcome (Czosnyka et al., 2001; Lam et al., 1997; Smielewski et al., 1997).  
This could possibly be explained by a disturbance in the pressure-volume (elastance) curve 
www.intechopen.com
 Brain Injury – Pathogenesis, Monitoring, Recovery and Management 
 
222 
that is steeper suggesting poor compliance of the brain (figure. 4). Since elevated ICP  
and changes in CBF are two key factors to consider in all severely injured brain patients 
(figure. 2), besides cerebral autoregulation, the concept of cerebral pulsation is also thought 
to play a significant role in head injury pathogenesis. 
 
 
Fig. 4. Pressure-volume curves of craniospinal contents. (A) is normal pressure-volume 
curve of compliant system and (B) is the pressure-volume curve when brain compliance is 
reduced. 
5.1 Monro-Kellie doctrine, cerebral autoregulation, cerebral pulsation, pulsatility and 
resistive index and brain compliance 
According to Monro-Kellie doctrine, the sum of the intracranial volumes of blood, brain and 
CSF is constant and that an increase in any one component must be offset by an equal 
decrease in another or else ICP rises. For traumatic brain injury, a pathological increase in 
brain volume due to cerebral oedema or an increase in blood volume would induce an 
initial reduction in CSF volume response. This has been traditionally viewed as CSF being 
forced out into the spinal dural sac to maintain ICP. This anatomical compensatory response 
can quickly become exhausted and further rise in ICP is expected. Since raised ICP can lead 
to reduction in CPP and therefore compromising CBF, the body finally has to utilise the 
second defence mechanism, functional compensatory response (augment the CBF). This type of 
compensatory response is to ensure the brain receives an adequate blood flow and hence 
counteracts the effect of raised ICP. Once the body compensatory responses (anatomical and 
functional) become overstretched, that is the only time we note a fast increase in ICP and 
striking reduction in brain compliance (the steep part of the elastance curve). This 
decompensatory phase is related to poor brain compliance, raised ICP and reduction in CBF 
(figure. 5, labelled as A,B and C). Besides cerebral autoregulation, increased in intracranial 
vessels pulsation is one of the mechanisms that could augment the CBF during ischaemic-
hypoxic events (Chan et al., 1992; Egnor et al., 2002; Muttaqin et al., 1993). Since both seem 
to be important, monitoring level of autoregulation and assessing the intracranial vessels 
pulsation are two parameters that should be done in NIC for multimodality monitoring. 
Cerebral autoregulation is normally tested or monitored with transcranial doppler by using 
static (vasopressor) or dynamic (Aaslid leg-cuff, carotid artery compression or tilt table 
declination) provoking test or with cerebrovascular reactivity index (PRx) whereby digitised 
ICPs is divided with digitised MAPs and focusing on their trends or values; positive values 
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imply that increases in MAP are positively associated with increases in ICP, suggesting 
autoregulatory impairment, whereas negative or flattened values indicate intact 
autoregulatory mechanism, with vasoconstriction and decreased or maintained ICPs in 
relation to surges in MAPs (figure 6) (Aaslid et al., 1989; Mitsis et al., 2006; Smielewski et al., 
1997; Timofeev et al., 2011; Zweifel et al., 2008). Similarly, assessing the intracranial vessels 
pulsation is made possible using transcranial doppler (TCD) and measuring the velocity of 
middle cerebral artery (MCA) and quoted as pulsatility (PI) or resistive index (RI). 
Researchers have found strong correlation between the RI or PI with raised ICP (Bellner et 
al., 2004; Gura et al., 2011; Voulgaris et al., 2005).   
 
 
Fig. 5. The correlation between ICP and CBF. The compensatory phase exists at the 
beginning of raised ICP and followed by the decompensatory phase in some cases with 
persistently raised ICP. There exist individual variations labeled as A, B or C with different 
degrees of ICP increment or CBF reduction. Similarly, there is also harmful compensatory 
phase, labeled as D,E and F, in which increased in CBF would cause increment in ICP 
(commonly induced by clinicians). The role of multimodality monitoring is to identify ICPY 
and CBFX and to identify the time-shift from compensatory to decompensatory or harmful 
compensatory phase. 
The correlation between intracranial brain pulsations and brain compliance can also be 
noted on ICP waveforms. A good ICP waveform looks similar to an arterial pressure wave 
(Ross & Eynon, 2005). There are three peaks (figure. 7, labelled A): a) P1 is known as 
percussion wave and produced by systolic arterial pressure transmitted from the choroid  
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Fig. 6. Positive and negative trends for the cerebrovascular pressure reactivity index (PRx). 
Positive trends signify impaired cerebral autoregulation whereas, negative and flattened 
trends denote intact autoregulation. 
plexus to the ventricle; b) P2 is the tidal wave, its shape is more variable and originated from 
central venous wave from the right atrium and correlated with venous volume or venous 
congestion, sinus pressure and brain pulsations in injured brain. P2 may also stand for 
overall brain compliance; c) P3 is the dicrotic wave and is due to closure of the aortic valves. 
In between P2 and P3, there is dicrotic notch which is also thought arising from the effect of 
aortic valves closure. In 1965, Lundberg described three time-dependent patterns of 
pressure waves in patients with raised ICP (Lundberg et al., 1965). Lundberg A or plateau 
waves are 50 – 100 mmHg high and last for 5 to 20 minutes. This type of pressure waves 
demonstrate an early functional compensatory response between raised ICP and CBF. 
Cerebral vasculatures start to dilate in response to intracranial hypertension and critically 
low CBF, however, this autoregulatory vasodilatory response can dangerously lead to 
further increment in ICP via increased in intracranial blood volume in some brain injured 
patients with impaired autoregulation (figure. 5, labelled as D,E and F). Lundberg B waves 
occur at frequency of 0.5 – 2/min and are up to 50 mmHg in amplitude. It is detectable in 
normal and some individuals with impaired cerebral autoregulation (Balestreri et al., 2004). 
Lundberg C waves last 4 to 5 minutes and are up to 20 mmHg in amplitude and are of little 
clinical significance. Studies on ICP waveforms and Lundberg patterns of pressure waves 
have demonstrated that in the presence of raised ICP and intact cerebral autoregulation, the 
brain is able to regulate or optimise its CBF through compensatory mechanisms. 
Maintainance of CBF can be made via autoregulatory cerebral vasculature dilatations and 
increased in cerebral vasculature pulsations. Since P2 indicates overall compliance of the 
brain, at an early stage of compensation the peak-interval between P1 and P2 is increased 
which signifies increased cerebral vasculature pulsations and increased brain compliance 
(figure.7, labelled B). In the presence of persistently raised ICP, this initial response is 
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followed by a gradual reduction in the peak-interval between P1 and P2 (P2 is nearly at 
the same level or is higher than P1) signifying decreased brain compliance as well as 
marked reduction in brain pulsations suggesting decreased distensibility or increased 
stiffness of the brain (figure.7, labelled C). This decompensatory phase starts when the 
body is unable to maintain an adequate CBF with simultaneous rapid increment in ICP 
and invariably manifests in various ways: a) reduced in any parameters that measured 
CBF; b) increased in RI measured with TCD; c) elevation in anaerobic metabolism 
parameters which commonly measured with microdialysis; d) retention of carbon dioxide, 
presence of hypoxia or acidosis and increased in brain temperature as measured by 
Neurotrends or Licox system  and e) change in EEG waveforms or alterations in evoked 
potentials. The time-shift from compensatory to decompensatory or harmful 
compensatory phase is not known unless ICP and various other monitorings are 
implemented on patients monitored in NIC. Therefore, the roles of multimodality 
monitoring are as follows: 
1. To identify early the potential dangerous effect of known vicious circle of ICP and CBF, 
therefore guiding the clinician to institute the appropriate mode of therapy (ICP or CPP 
targeted therapy) with closed neuromonitoring 
2. To identify the time-shift from compensatory to decompensatory or harmful 
compensatory phase, therefore helping the clinician to proceed with end-tier therapy 
(decompressive craniectomy or barbiturate coma therapy) when absolutely indicated 
3. To help clinician understand the complex pathophysiology of severely injured brain, 
therefore creating a future possibility to develop new and innovative therapy 
 
 
Fig. 7. Intracranial pressure waveforms. In a non-compliant system, P2 wave is exceeding P1. 
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5.1.1 Vicious circle of ICP and CBF: ICP and CPP targeted therapy versus 
multimodality monitoring 
In previous sections, we recognised that an increase in ICP sets in an autoregulatory 
response to compensate for a reduction in CBF. Since CPP is proportional to CBF, increment 
in ICP would cause decrement in CPP. This is easily understood from the equation: CPP = 
MAP – ICP, whereby raised ICP causes reduction in CPP when MAPs are kept constant. 
Reduced CPP can be corrected by raising the MAP or by reducing the ICP. Reduction in ICP 
is normally called ICP targeted therapy, whilst CPP targeted therapy corrects the reduced 
CPP by raising the MAP. In 2003, Young recommended an aggressive CPP management for 
patients with elevated ICP (Young et al., 2003). Four patients in their study had 
comparatively good neurological outcome after receiving such management for extremely 
high ICP. Nonetheless, in some severely injured brain patients who have high CPP values or 
those received an aggressive CPP management appeared to develop cerebral oedema or 
brain swelling and had poor outcomes. This phenomenon is thought to arise from 
impairment in cerebral autoregulatory mechanisms (Dickman et al., 1991; Nujaimin et al., 
2009; Zweifel et al., 2008). In patients with an impaired cerebral autoregulation, ICP targeted 
therapy seems more appropriate than CPP targeted therapy. This is mainly because of the 
vicious circle that can occur in patients with impaired cerebral autoregulation whereby ICP 
is further elevated by elevating the CPP (figure 5, labelled D,E and F). Many studies have 
shown a strong association between an elevated ICP and poor patient outcome in head 
injury (Cooper et al., 2008; Eberle et al., 2010; Idris et al., 2007). In most cases with poor 
outcome, both, elevated ICP and low CPP values appeared common features. Therefore it 
seems prudent to conclude that in such patients, the emphasis should not only on raising 
CPP but also on lowering the ICP to gain better outcome. In fact, the combination of ICP and 
CPP therapy forms the basis of the guidelines or protocols proposed by the US Brain 
Trauma Foundation (Bullock et al., 1996), European Brain Injury Consortium (EBIC) (Maas 
et al., 1997), Addenbrooke protocol from the Cambridge (Patel et al., 2002) and Lund 
protocol (that is still considering the importance of reducing ICP and improving the CPP) 
(Asgeirsson et al., 1994). In relation to figure 5, it is a daunting task to speculate which 
patient will benefit from CPP or ICP targeted therapy. Additional tests or monitoring are 
obviously needed to facilitate this difficult task in deciding which patients are likely to 
tolerate CPP targeted therapy. Since multimodality monitoring does monitor various 
cerebral parameters (ICP, CPP and CBF) and at the same time allowing cerebral 
autoregulation test or monitoring to be done, therefore it serves as an appropriate 
monitoring approach. Multimodality monitoring can detect not only further increment in 
ICP values but also the presence of any compromise in CBF in patients who already have 
elevated, extremely elevated or lethal levels of ICP and still undergoing CPP targeted 
therapy. 
5.1.2 Shift from compensatory to decompensatory or harmful compensatory  
phase – Role of multimodality monitoring 
Intracranial hypertension (high ICP/low CPP) and reduction in CBF are two important 
parameters that determine the outcome of severely injured brain patients. Figure 2 
illustrates cerebral ischaemic-hypoxic insults are the core events that trigger various vicious 
circles, including intracranial hypertension. Therefore, CBF monitoring should be 
incorporated into the standard care for severely injured brain patients in the NIC. The 
multimodality monitoring for the ICP and CBF offers crucial information on the status of 
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cerebral oxygenation, nutrition and function. The combination of various monitored 
parameters can cross-validate one another and can give indications as to the phase the brain 
is in for the managing clinicians (figure 5). Patients who are in the compensatory phase with 
raised ICP and undergoing CPP targeted therapy may not yet be a candidate for 
decompressive craniectomy or barbiturate therapy as long as the ICP is kept stable and CBF 
parameters are within an acceptable range. However, those with deteriorating CBF 
parameters (figure 5, labelled A,B and C) and/or persistently raised ICP (figure 5, labelled 
A,B,C,D,E and F) may be considered for above mentioned end-tier therapy. In summary, 
besides its potential to safe guard the CPP targeted therapy, multimodality monitoring of 
the severely injured brain patients aids clinicians to decide on the appropriate timing for 
end-tier therapy, decomperessive craniectomy or barbiturate therapy. 
6. Measuring the two major parameters: ICP and CBF 
The multimodality monitoring can be viewed as way of monitoring two important 
parameters that play significant roles in the pathogenesis of ischaemic-hypoxic events, 
namely, the ICP and CBF. 
6.1 Intracranial pressure 
The ICP is normally monitored until an acceptable upper limit of 20 mmHg (Balestreri et al., 
2006). This is attained by using either ventricular catheter if the ventricles are opened or a 
compliance monitor (Spiegelberg GmbH & Co., Hamburg, Germany) or an 
intraparenchymal ICP, using Codman (Codman, Randolph, MA, USA) or Camino 
transducers (Camino Laboratories, San Diego, CA)(Idris et al., 2007; Isa et al., 2003). If the 
ICP values persistently read more than 20 mmHg and/or direct calculation of cerebral 
perfusion pressure (CPP) appears less than 50 mmHg, draining of CSF is warranted. If the 
ICP remains high, other modes of therapy such as adding muscle relaxants, giving mannitol 
or hypertonic saline, temporary hyperventilation, hypothermia with cooling blanket and 
fans are usually considered. At this stage, further investigation with CT brain is justifiable 
provided that these additonal steps fail to reduce the ICP values. The subsequent treatment 
should be based on the new imaging and monitored parameters. Generally, if the CT brain 
revealed no new surgical lesion but the brain appeared swollen, the ICP values remained 
high (or CPP values remained low) and/or presence of abnormal cerebral blood flow 
parameters, the patient should then be treated with either one of the following: 
1. Bifrontal decompressive craniectomy and dura augmentation for diffuse brain swelling 
without midline shift, or 
2. Unilateral  wide decompressive craniectomy and dura augmentation for diffuse brain 
swelling and presence of midline shift, or  
3. Barbiturate therapy until burst suppression attained on continuous EEG monitoring. 
Nonetheless, if the ICP values remain persistently high, decompressive craniectomy can 
still be considered.  
For patients with persistently low CPP values without a corresponding raised ICP, 
decompressive craniectomy surgery or barbiturate therapy is not yet indicated. Instead, 
these patients should be treated with inotropes and/or hypervolumic therapy to increase 
CPP values. If by implementing CPP targeted therapy and the ICP started to increase, then 
the end-tier therapy should now be considered.  
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6.2 Cerebral blood flow 
CBF can be measured in various ways. Measuring CBF can be classified into 4 ways: 
a. Direct measurement of CBF 
b. Indirect measurement of CBF 
c. Quantitative measurement of CBF 
d. Qualitative measurement of CBF 
Quantitative and qualitative measurements are employed mainly for research purposes and 
hardly used during monitoring of severely brain injured patients in NIC. Examples include 
using radioisotope or tracer to measure CBF with imaging modality such as PET or SPECT 
scan. 
A) Direct measurement of CBF 
The direct measurement of CBF can be made by means of thermal diffusion techniques 
(Saber 2000) and LASER Doppler Flowmetry (LDF) which measure the local or regional 
CBF.  
1. Thermal diffusion technique (Saber 2000) 
The thermal diffusion measurement of cortical CBF is based on the thermal conductivity of 
cortical tissue (Carter et al., 1982; Dickman et al., 1991). The Saber 2000 regional cerebral 
blood flow (rCBF) sensor (flowtronics, Phoenix, AZ) consists of two small flat gold plates, 
one of which is neutral and the other heated, is placed through a burr hole or craniotomy on 
a cortical region of interest. The rCBF is estimated from the temperature difference between 
these two plates. Then, a microprocessor continuously converts the temperature difference 
to CBF in ml/100g/min. In practice, the sensor measures cortical area of approximately 1 cm 
deep in the cerebral hemisphere and 3 cm by implication. Its sensor plates are 24-k gold, 
whereas its wires are solid silver and teflon-coated. Although rCBF is not representative of 
blood flow in the whole hemisphere or in deeper regions of the brain, continuous 
measurement of relative changes in days after severe head injury may be of great value in 
guiding clinical management as an indirect measurement of perfusion status of the brain. 
Normal rCBF measured by Saber 2000 should be ≥ 30 ml/100g/min. 
 
 
Fig. 8. Saber 2000 measures regional cerebral blood flow 
2. LASER Doppler Flowmetry (LDF) 
LDF measures continuously the local microcirculatory blood flow. The method is based on the 
principle of doppler shift. Monochromatic LASER light reflected from stationary tissue 
remains unchanged in frequency, but when it is reflected from moving blood cells, it 
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undergoes a frequency shift and therefore light reflected from the microcirculation measures 
the movements of red blood cells (Meyerson et al., 1991). The light is carried by a fibreoptic 
probe and the reflected light is converted into an electrical signal from which several values 
are derived. The flux (flow unit) represents the movement and concentrations of blood cells 
through the microvasculature. It is derived from the concentration of moving blood cells 
(CMBC) in the measured volume multiplied by the mean velocity. All three values, flux, 
CMBC and velocity are continuously recorded and displayed by the computer (Bolognese et 
al., 1993). LDF measures the local flow within a very small sample volume of approximately 1 
mm3. LDF can also be used to measure the state of cerebral autoregulation via CO2 reactivity. 
B) Indirect measurement of CBF 
The indirect measurement of CBF consists of near infrared spectroscopy (NIRS), jugular 
bulb venous oximetry (SjVO2), transcranial doppler sonography (TCD), cerebral interstitial 
tissue oxygen (PtiO2) and carbon dioxide tension (PtiCO2), brain pH and temperature, 
intracerebral microdialysis and electrical function monitoring. 
1. Near infrared spectroscopy (NIRS) 
It is a non invasive monitoring that detects changes in brain oxygenation, CBF and cerebral 
blood volume. NIRS depends upon the relative transparency of biological tissue to light in 
the near-infrared spectrum. The absorption of oxyhemoglobin, deoxyhemoglobin and 
oxidized cytochrome can be detected transcranially. In adults, only certain brain areas can 
be monitored because of bone thickness produces a scattering of the light spectrum (Elwell 
et al., 1993).  This made NIRS less accurate and only focal measurement is feasible. 
2. Jugular bulb venous oximetry (SjVO2) 
A 5G fibreoptic oxygen saturation catheter is inserted percutaneously in a retrograde 
direction into the internal jugular vein. The tip of the catheter must be placed within the 
dominant jugular bulb which is determined by separate test compression on each internal 
jugular vein and note an increment in ICP values. Prior to monitoring, its position must be 
verified by the mastoid x-ray. SjVO2 can be used to calculate arteriovenous difference or 
cerebral oxygen extraction (AVDO2) and to monitor cerebral oxygenation. Both determine 
the status of cerebral metabolic rate for oxygen (CMRO2) and CBF which are coupled when 
under physiological conditions. The relationships between CBF, CMRO2 and AVDO2 can be 
summarised by the formula CMRO2 = CBF × AVDO2. The normal values for AVDO2 is 
approximately 6.5 ml O2/100 ml blood, for CMRO2 is 3.2 ml O2/100g/min and for cerebral 
oxygenation ranges between 50% - 75% (Idris et al., 2007; Muizelaar & Schroder, 1994). 
Ischaemic brain with low CBF exhibits low SjVO2 reading of less than 50%, whereas for the 
hyperaemic brain, the reading is more than 75%. Similarly, in brain dead patient where no 
uptake of oxygen occurred, the SjVO2 would also be higher than 75%.  
 
 
Fig. 9. Jugular bulb venous oximetry monitor 
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3. Transcranial doppler sonography (TCD) 
Transcranial doppler provides a mean of measuring relative changes in CBF by observing 
blood flow velocity (FV) in basal cerebral arteries, mostly on middle cerebral artery (MCA) 
or anterior cerebral artery (ACA) (Muttaqin et al., 1993). It uses doppler shift as a basic 
principle. This shift is monitored intermittently by using a 2 MHz pulsed TCD 
ultrasonography probe (model MultiDop 2; DWL Electronishe System GmbH, Sipplingen, 
Germany) inserted at depths of between 4 to 6 cm. TCD measures the velocity of red blood 
cell moving within a vessel, quoted in cm/sec. In contrast, CBF is a three dimensional 
measure of volume of blood delivered per unit of cerebral tissue per unit of time, quoted as 
ml/100g/min. As the two parameters are quantitatively different, the correlation between 
absolute values of FV and CBF is poor. However, in normal individuals, the cross-sectional 
area of the insonated blood vessels remains constant, hence, the CBF and FV should vary 
directly with one another. In traumatic brain injury, the blood vessel diameter may be 
altered by changes in ICP (altered autoregulation and vascular pulsation) and/or the 
possible effect of vasospasm, reducing the reliability of the relationship between relative 
CBF and FV. This variable relationship between the absolute FV and CBF is a clear 
disadvantage, as reflected by the normal variation in MCA FV of between 35 – 90 cm/sec in 
the awake resting state. Thus caution is needed in interpreting TCD data in its estimate of 
CBF. Abnormally low (ischaemic brain) or high (vasospasm or hyperaemic brain) FV must 
be interpreted carefully and preferably in conjunction with other CBF monitoring 
parameters (Idris et al., 2007; Isa et al., 2003).  
 
 
Fig. 10. Continuous transcranial doppler sonography monitoring in neurointensive care 
4. Cerebral interstitial tissue oxygen tension (PtiO2), carbon dioxide (PtiCO2), pH and temperature 
measured by Licox or Neurotrend/Paratrend system. 
Neurotrend (old system called Paratrend 7TM) system (Codman, Johnson & Johnson, 
Raynham, MA, USA) is an effective method of measuring tissue cerebral oxygen tension 
(PtiO2), along with carbon dioxide tissue levels (PtiCO2), brain pH and brain temperature 
(Charbel et al., 1997). On the other hand, Licox system (GMS, Kiel-Mielkendorf, Germany) is 
capable in measuring only PtiO2 and brain temperature. The importance of CBF to maintain 
neuronal viability is well known. In brain tissue, this can be defined as maintaining tissue 
oxygenation and a metabolic environment for oxidative energy production and therefore for 
optimal neuronal function. Patients with brain ischaemia secondary to head injury are 
thought to have changes in brain tissue partial pressure for oxygen (Po2) and carbon dioxide 
(Pco2), pH and temperature. During ischaemia, the Po2 decreases due to increased 
consumption, Pco2 increases due to decreased clearance and the interstitial tissue 
environment is acidic with falling pH and accumulation of toxic metabolites. The system can 
provide continuous quantitative measurements of regional brain. Normally, the sensor is 
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inserted into peri-contusional, peri-infarted, peri-haemorrhagic or peri-lacerated brain areas. 
The purpose of measuring these parameters is to safeguard the ischaemic or penumbra 
areas of brain which are compromised and the measured abnormal parameters could reflect 
the globally threatened CBF. Normal values for these parameters have been acquired 
experimentally, whereby in normal individuals PtiO2 ranges between 37 to 48 mmHg. 
However, hypoxia of brain tissue has been reported to occur when PtiO2 is < 15 mmHg 
(Hoffman et al., 1996; van Santbrink et al., 1996). PtiCO2 normal values is within the range of 
49 to 59 mmHg, normal brain pH is 7 to 7.16 and normal brain temperature is 0.3 to 0.5 
higher than the normal range of core body temperature which is within 36 to 39°C (the ideal 
core body temperature is the midpoint of this range, that is 37.7°C) (Hoffman et al., 1996; 
Sakai et al., 2011; Zauner et al., 1995). Brain temperature of healthy person denotes the 
balance between two processes: cerebral metabolism and CBF. Under normal conditions, the 
brain metabolises glucose via the Krebs cycle to carbon dioxide, water and adenosine 
triphosphate (ATP). Cells in the brain use ATP as energy resource and consequently 
generate heat. CMRO2 and cerebral metabolic rate for glucose (CMRglu) are the factors that 
directly related to heat production in the brain. Conversely, the heat is removed by CBF. 
Therefore, in presence of ischaemia (reduction in CBF), the brain temperature is higher than 
normal (Sakai et al., 2011).  
 
 
Fig. 11. A: Neurotrend and B: Licox system. Neurotrend is capable of measuring brain 
temperature, brain pH, PtiO2, PtiCO2 and HCO3 whereas Licox only measures PtiO2 and 
brain temperature. 
5. Intracerebral microdialysis 
Intracerebral microdialysis (CMA70 and CMA 71 catheters and CMA600 and ISCUS 
analyser; CMA Microdialysis AB, Solna, Sweden) enables endogenous substances in the 
extracellular fluid of the brain to be retrieved. Excitatory amino acids, neurotransmitter, 
electrolytes and energy-related metabolites are released in abnormal quantities after severe 
head injury. There would be an increase in glutamate, glycerol, aspartate, K+ and 
lactate/pyruvate ratio and a decrease in glucose level in head injured patient with cerebral 
ischaemia (Timofeev et al., 2011). Their continuous measurements via dialysis principle can 
help the neurointensivist to correlate their findings with imaging of the brain, other 
monitored parameters and patient conditions to decide on the appropriate management. 
6) Electrical function monitoring and bispectral index (BIS) 
Electrophysiological monitoring is a measurement of brain electrical function which is 
regarded as vital in nervous communication. The electroencephalogram (EEG) and evoked 
potentials such as visual evoked potential (VEP), brainstem auditory evoked potential 
(BAEP) and somatosensory evoked potential (SSEP) can give valuable information 
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regarding the status of CBF and metabolism. The normal CBF is 45 to 55 ml/100g/min, and 
the electrical function is impaired (isoelectric silence) if CBF is < 23 ml/100g/min with 
irreversible damage occurs if CBF is < 8 ml/100g/min. Deterioration in their values 
correspond to reduced levels of transcranial oxygen extraction and hence CBF (Jordan, 1993; 
Procaccio et al., 2001). Besides, continuous bedside EEG monitoring is the best method for 
detecting non-convulsive seizures and presence of significant amount of background 
slowing frequencies informs the neurointensivist regarding the depth of coma and 
prognosis of the severely injured brain patients.  
 
 
Fig. 12. Intracerebral microdialysis. 
The bispectral index (BIS) of the electroencephalogram is a weighted sum of 
electroencephalographic subparameters containing time domain, frequency domain and 
higher-order spectral information, which are optimized to correlate maximally with clinical 
signs of hypnosis (Fabregas et al., 2004) and CBF (Myles, 2009). BIS system is patched onto 
the forehead of patients. The aim is to keep the general anaesthesia effect or adequate 
hypnotic effect at 40 – 60% (Gan et al., 1997). The targeted values indicate adequacy of 
muscle relaxants and sedation to reduce the cerebral metabolic rate and ICP. Inadequacy 
(higher values) indicates higher titrating dose of sedative medications is required and 
equally important is to realise that an abnormally low or presence of sudden deterioration in 
BIS values should alert the neurointensivist for possible CBF compromise. However, this 
should be interpreted carefully with other cerebral monitoring to realise its importance. 
 
 
Fig. 13. A: Electrical function monitoring and B: The BIS system was patched onto the 
patient’s forehead. 
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7. Interpretation of data and management steps 
In general, two parameters are monitored during multimodality monitoring for severe head 
injury: ICP and CBF (Idris et al., 2007). Combination of these two important parameters help 
neurointensivist to know the status of brain autoregulation, either impaired or intact 
(cerebrovascular reactivity index or PRx)(Smielewski et al., 1997). Therefore, based upon this 
observation, the clinician can opt for ICP or CPP targeted therapy. ICP targeted therapy 
aims to reach ICP < 20 mmHg and CPP targeted therapy aims CPP > 50 mmHg. The 
commonly targeted CPP is 60 - 70 mmHg, but when managing patients with impaired 
cerebral autoregulation, the targeted CPP should be kept < 50 – 60 mmHg. Recently, 
Johnson studied status of cerebral autoregulation, targeted CPP and clinical outcome for 
trauma patients and found that in patients with impaired cerebrovascular autoregulation, 
the favorable outcome was noted when CPP kept less than 50 - 60 mmHg (Johnson et al., 
2011). Besides ICP (ICP is a factor in pathophysiology of midline shift, mass effect, 
herniation syndromes), monitoring CBF (CBF is a factor in pathophysiology of ischaemic-
hypoxic damage or cerebral infarction) is also important and plays significant role in 
determining patient’s outcome as depicted in figure 2 and discussed in details above. Since 
currently there is still no optimal and practical method to be used in NIC for measuring 
CBF, other methods of monitoring (besides ICP) in ‘multimodality monitoring’ are trying to 
estimate the CBF values for either the whole brain (CPP, SjVO2, TCD, electrical function, 
EEG and BIS) or for only at certain region of the brain (Saber 2000, LDF, NIRS, Neurotrends 
and cerebral microdialysis). The main goal of these modalities can be viewed as to identify 
early and at a reversible stage either intracranial hypertension or ischaemic-hypoxic insults 
(other goal is to identify subclinical seizures as discussed above).  
In term of CBF (management for ICP or CPP has been discussed previously), the clinician 
effort consists of several aims: to optimize CBF to all regions of the brain whilst to prevent 
expansion of intracranial haematoma or contusion and to restore perfusion of the penumbra 
area. Regional CBF (rCBF) can be measured with many methods as mentioned earlier. The 
Saber 2000 which can be laid onto the area of interest seems more appropriate when the 
clinician wants to safeguard the peri-contusional, peri-haematoma or peri-ischaemic areas. 
The combination of Saber 2000 rCBF monitoring with microdialysis, Licox or Neurotrends 
system would certainly be a helpful approach. Reduction or abnormality in almost all 
parameters would validate one another and hint corrective measures for the clinician to 
take. Similarly, the availability of information on the more globalised CBF (gCBF) 
monitorings such as SjVO2, would indicate any compromise to CBF on a more global basis 
to instigate appropriate corrective actions to prevent ischaemia from inflicting more areas of 
the brain. During ischaemic insults, if both rCBF (Saber 2000 CBF < 30 ml/100g/min; PtiO2 < 
15 mmHg; PtiCO2 > 59 mmHg, hyperthermia, acidotic profiles on pH or microdialysis) and 
gCBF (SjVO2 of decreasing trends or persistent values of less than 50%, abnormal EEGs, low 
value of TCDs) are abnormal, cerebral hypoperfusion is the likeliest suspicion. Further 
actions are needed to try and correct these abnormalities, especially for correctable causes. 
For instance, CBF may be low because of low in mean arterial pressure (MAP) due to the 
new onset cardiac abnormalities such as abnormal rhythms or abnormal stroke volume. 
Other related possibilities include overdosage or side effects of drugs such as anti-epileptics 
or overzealous use of inotropic drugs, new onset pneumothorax, cerebral or cardiac 
embolisation or cerebral vessels vasospasm. TCD monitoring of MCAs, ACAs and other 
major intracranial or neck vessels can readily diagnose vasospasm. Contradictory values 
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between TCDs and the stated parameters discussed in earlier sections would alert the 
clinician towards cerebral vasospasm as the aetiology for cerebral hypoperfusion (high TCD 
but reduce CBF parameters). Triple-H therapy (includes expanding the plasma volume or 
hypervolemia, hemodilution and importantly hypertension), nimodipine or urgent 
interventional angiography for vasospasm should then be attempted to treat the identified 
problem. If only rCBF is impaired, steps should be taken to augment blood flow to those 
compromised areas only. However, currently, there is limited choice available for clinician 
to optimize rCBF.  Most of the corrective measures for rCBF are in fact lending to optimize 
the gCBF. By augmenting the gCBF, the clinician may face notorious effect of ‘hyperaemic 
insult’ which in cases with markedly impaired cerebral autoregulation can be associated 
with brain swelling or odema and further elevation in ICPs that can aggravate the 
ischaemic-hypoxic circle. Therefore, multimodality monitoring offers more parameters to be 
closely considered when practicing ‘CPP targeted therapy’. By pushing the CPP, the 
clinician should look at SjVO2 which can become more than 75% suggesting cerebral 
hyperaemia and patterns of TCDs values which can become abnormally high. The 
aggressive CPP targeted therapy should not stop unless there is simultaneous elevation in 
ICPs, especially with parallel gradual emergence of deterioration in other monitored 
parameters (especially from Licox or Neurotrends and cerebral microdialysis), suggesting 
presence of markedly impaired cerebral autoregulation and evolving brain swelling which 
finally ends up with reduction in CBF in ‘that particular patient’. If ICPs become elevated 
(with other abnormal parameters suggesting/confirming reliable ICPs), the CPP targeted 
therapy should be stopped and measures such as lowering the MAP, reduction in plasma 
volume or inducing diuresis (with mannitol or diuretics), ICP lowering measures (such as 
mannitol or hypertonic saline, draining of CSF, adding or increasing sedative agent or 
muscle relaxant) should be taken. Decompressive craniectomy or barbiturate therapy should 
be reserved for patients who failed to respond to the initial measures and displayed 
concurrent features of time shift from compensatory to harmful compensatory or 
decompensatory phase. 
8. Malaysia experience in multimodality monitoring   
Our initial study published in 2003 on outcome of severe traumatic brain injury comparing 
the 3 monitoring approaches (multimodality, ICP alone and no cranial monitoring) revealed 
a statistically significant difference in the proportions of good outcomes between the 
multimodality group compared with the group of patients that underwent a single 
intracranial-based monitoring method and the group that received no monitoring (p = 0.003) 
based on a disability rating scale after a follow up of 12 months. Death was the focus of 
outcome in this study in which the multimodality approach to monitoring had superior 
results (Isa et al., 2003). The subsequent studies done in our centre were prognostic and cost 
effectiveness analysis studies of using different monitoring modalities in treating severe 
traumatic brain injury which were completed in 2004 and published in 2007 (Ibrahim et al., 
2007; Idris et al., 2007). 
8.1 Prognostic and cost effectiveness analysis studies of using different monitoring 
modalities in treating severe traumatic brain injury 
Between June 2002 and March 2004, 52 adult patients with severe traumatic non penetrating 
head injury were recruited into our prospective randomised study at our University 
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Hospital, Universiti Sains Malaysia. The aim of the study was to investigate whether 
multimodality monitoring in severe traumatic brain injury would alter the outcome score. 
All adult patients, age of more than 14 years old with traumatic non penetrating head injury 
who had GCS of less than 9 and CT brain without infratentorial pathology were included. 
We excluded those who had a unilateral or bilateral fixed and dilated pupils resulted from 
an on-going herniation, brain dead patient and patient known to have any condition that 
lowering his or her functional status score. The randomisation process was made to allocate 
to either multimodality monitoring or to standard ICP monitoring. In the multimodality 
group, we monitored basic intensive care parameters and multiple cerebral parameters. In 
the standard ICP monitoring group, only ICP was monitored together with basic intensive 
care parameters. Monitoring proceeded for at least 3 days if uneventful. We recorded the 
outcome at 6 months post treatment using the Barthel index score. 
The sixth month’s outcome between those groups (26 patients in each group) was not 
statistically significant (p < 0.48). However, the percentage of cases independent at 6 months 
was higher in the multimodality group compared with single modality group, 21.2% and 
17.3% respectively. The multimodality monitoring group had also lower percentage of 
dependent cases at 6 months in comparison to the single ICP modality group, 28.8% and 
32.7% respectively. The univariate analysis revealed, age (p < 0.03), GCS on arrival (p < 
0.01), 24 hours fluid balance at day 2 of monitoring (p < 0.01), serum sodium (p < 0.03) 
and intracranial pressure at day 3 of monitoring (p < 0.01) were correlated with the 
outcomes. The trends of the parameters disclosed younger, higher GCS, lower injury 
severity score and Marshall grade would have a higher chance to be independent at 6 
months post trauma. Tachycardic, hyperthermic, hypo- and hyper-volumic patients 
during the first 3 days of monitoring tend to be dependent at 6 months post injury. The 
dependent patients also tend to be acidotic or alkalotic for their arterial blood gases, have 
Paco2 of < 20 mmHg or Paco2 > 45 mmHg, blood haemoglobin level of < 8 g/dl, high blood 
urea and sodium, have persistently high ICP of more than 20 mmHg, CPP of < 55 mmHg, 
SjVO2 of < 50% or > 75%, rCBF < 35 ml/100g/min, TCD MCA flow velocity of < 35 
cm/sec and PtiO2 of < 15 mmHg. Despite no significant statistical difference between  
the multimodality and single modality group, a possiblity of better outcome obtained 
with multimodality monitoring technique remains because of higher cases with 
independent status observed in that group. Obviously, this requires larger sample size for 
future study (Idris et al., 2007). We also did a study on cost effectiveness analysis of using 
multiple neuromodalities in treating severe traumatic brain injury. Despite a higher cost 
in multimodality monitoring, the application of multimodality monitoring for severe 
traumatic brain injury was more cost-effective (considering the cost of the equipment  
and the clinical outcome of the studied patients) than baseline neuromonitoring  
(p < 0.001)(Ibrahim et al., 2007).  
8.2 Limitation of multimodality monitoring 
Despite various available cerebral monitoring, the current limitation in managing severely 
injured brain is the therapy to optimize all monitored parameters. Except for high ICP, we 
are yet to have any accepted standard for treating abnormalities detected by CBF/CPP 
monitoring. Future works should focus on improving these diagnostic monitoring tools as 
well as ways to treat or correct those detected abnormalities. Research on therapy is 
continuing and one of the potential therapies is cerebral hypothermia. 
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Fig. 14. Multimodality monitoring for a patient with severe traumatic brain injury. 
9. The future of monitoring and managing the severely injured brain – 
multimodality monitoring and cerebral hypothermia    
Figure 2 illustrates various pathways that promote cerebral ischaemic-hypoxic events which 
can lead to cell death or apoptosis. Interestingly, one can take note that these pathways are 
mostly temperature dependent and therefore can be mitigated with cerebral hypothermia. 
In 2006, Vincent and Polderman reviewed the neuroprotective mechanisms underlying 
hypothermia and listed out various benefits of hypothermic therapy (Vincent & Polderman, 
2006). Hypothermia can inhibit the activation of caspase enzymes, prevents or mitigates 
mitochondrial dysfunction, decrease the metabolism as well as decrease the overload of 
excitatory neurotransmitters such as glutamate and free oxygen radicals, modify the cellular 
disorders of intracellular ion concentrations, suppress the inflammatory and immunological 
responses and epileptic activity, reduce the disruption in blood brain barrier, vascular 
permeability and oedema, improve the microcirculatory circuits and intra- and extra-
cellular acidosis, correct the hyperthemia after brain injury, influence the local secretion of 
various vasoactive mediators secreted by the endothelium and enhance expression of 
immediate early genes and cold shock proteins. Building on the vast benefits of cerebral 
hypothermia, currently underway is a locally adapted approach to induce hypothermia in 
severely injured brain patients using a direct method and study their outcomes. 
9.1 Our current study - Direct brain hypothermia for trauma patient with Glasgow 
coma score of 6 and 7  
The objective 
To determine the effect of direct focal brain cooling on outcomes of severely injured brain 
patients. 
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Materials and Methods 
This is a randomized controlled study following an approval by the research and ethics 
committee of Universiti Sains Malaysia (USM). All adult patients with severe traumatic 
brain injury with GCS score of 6 - 7 and require decompressive craniectomy (DC) will be 
screened for eligibility to be recruited into this study. Once included, the patient will be 
randomized to either group A or B. Group A (treatment group) patients will receive therapy 
with direct focal brain cooling and group B is a control group, consists of patients who do 
not have direct focal brain cooling therapy. All patients will have ICP, Licox, BIS, EEGs and 
cardiac parameters monitoring during cooling period, and bloods will be drawn for 
immunological parameters prior to surgery and after local cooling therapy to the brain. This 
mode of multimodality monitoring and therapy will last for 24 - 48 hours, or longer if 
intracranial pressure parameters stays abnormal. The neurosurgical DC is a standard 
operation. A unilateral DC is planned for patients with the presence of ipsilateral pathology 
with midline shift and a bifrontal DC for brain swelling in patients with or without frontal 
pathology but in the absence of midline shift. The monitoring and therapy given after the 
surgery are the standard therapy for severely injured brain.  
Direct focal brain cooling method is achieved through continual irrigation of the brain with 
cold Hartmann’s solution in which the temperature of the infused fluid is divided into 2 
groups as follows: 1. deep cooling (Hartmann’s temperature of 20 - 29 degree celcius) and 2. 
mild cooling (Hartmann’s temperature of 30 - 36 degree celcius). The cold Hartmann’s 
solution is infused via neurojaf external ventricular drainage (EVD) with multiple modified-
extra holes catheter which is placed superior to the dura flap and in contact with the surface 
of the brain. It acts like rain flushing through the surface of the swollen brain, and with 
pulsation of the brain, the cold fluid is expected to be distributed to other areas of the brain. 
The infusion rate is targeted at 500 mls of Hartmann’s solution within 7 hours (70 mls/hr). 
Because of the position of the head in NIC, the second draining tube will be inserted at the 
lower part of the craniectomy flap outside the dura which at some areas, the closure is 
purposely made loose to drain the excess fluid with low suction pressure. The temperature 
of the infused Hartmann’s solution is always checked via the three way connector, draining 
the fluid out to the collection port for temperature assessment. If temperature reading is 
under or above the intended value, new solution with correct intended temperature will 
replace the previous one. All patients will have CT scan done if the ICP shows persistently 
raised values despite standard therapies being given. This is important to exclude any new 
surgical lesions and to exclude the retention of infused solution as a cause of raised ICP. If 
the ICPs show normal values, the CT scan of the brain will be done after 48 hours of therapy 
prior to removal of the EVD tube to document the location of the EVD tip. The outcome 
assessment for this study is the Glasgow Outcome Score at discharge and at 6 months after 
trauma and requirement for tracheostomy together with number of days ventilated in NIC.   
Preliminary Results   
Based on the preliminary recruitment of 7 patients in each group, there was significant 
difference in outcome upon discharge with better outcome score for the cooling group (p < 
0.02). In the cooling group, five patients had good GOS of 4 [independent status] and one 
patient attained dependent status with GOS of 3 [dependent]. The remaining one patient in 
this group who has an initial GOS of 3 had sudden onset aspiration pneumonia and died 
(GOS upon discharge scored as 1). On the contrary, five patients had GOS of 3 and two 
patients with GOS of 2 [all were dependent status] in the non cooling-control group. 
Furthermore, there were marked reductions in the ICP and brain temperature, and 
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improvement in PtiO2 and CPP of patients who had received cooling treatment. There was 
also faster ventilator weaning in the cooling group with median duration of 7 days 
compared to the control group of 9 days duration. Detailed analysis is yet performed 
because this study is still ongoing. 
 
 
Fig. 15. The typical multimodality monitoring set up for the randomized controlled trial 
involving the management of the severely injured brain with hypothermia at our NIC, 
University Hospital, Universiti Sains Malaysia 
10. Conclusion   
The pathophysiology of the severe non-penetrating traumatic brain injury involves complex 
chain of events at molecular, cellular or vascular levels. These pathophysiological processes 
extend beyond the confine of the brain as they also involve other body systems such as the 
cardiopulmonary system. Understanding these complex mechanisms is vital in our efforts to 
expand the usefulness of multimodality monitoring for the severely injured brain patients. 
However monitoring alone will not greatly alter the outcome, therefore future research 
should also focus on the therapeutic aspects of ICP and CBF monitored parameters. 
Currently, multimodality monitoring of the brain together with therapeutic cerebral 
hypothermia hold leading promises in the monitoring and treatment of the severely injured 
brain patients. 
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